These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25320284)

  • 1. TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.
    Govers C; Sebestyén Z; Roszik J; van Brakel M; Berrevoets C; Szöőr Á; Panoutsopoulou K; Broertjes M; Van T; Vereb G; Szöllősi J; Debets R
    J Immunol; 2014 Nov; 193(10):5315-26. PubMed ID: 25320284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.
    Pouw N; Treffers-Westerlaken E; Mondino A; Lamers C; Debets R
    Mol Immunol; 2010 Apr; 47(7-8):1411-20. PubMed ID: 20303179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:ζ, a candidate transgene for TCR gene therapy.
    Roszik J; Sebestyén Z; Govers C; Guri Y; Szöor A; Pályi-Krekk Z; Vereb G; Nagy P; Szöllosi J; Debets R
    Eur J Immunol; 2011 May; 41(5):1288-97. PubMed ID: 21469084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
    Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
    Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity.
    Ankri C; Shamalov K; Horovitz-Fried M; Mauer S; Cohen CJ
    J Immunol; 2013 Oct; 191(8):4121-9. PubMed ID: 24026081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters.
    Yokosuka T; Saito T
    Immunol Rev; 2009 May; 229(1):27-40. PubMed ID: 19426213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
    Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
    J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and molecular characterization of human chimeric T-cell antigen receptors specific for carcinoembryonic antigen.
    Shirasu N; Shibaguci H; Kuroki M; Yamada H; Kuroki M
    Anticancer Res; 2010 Jul; 30(7):2731-8. PubMed ID: 20683006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells.
    Schneider OD; Weiss AA; Miller WE
    Infect Immun; 2007 Aug; 75(8):4040-9. PubMed ID: 17562776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
    Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
    J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
    Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
    J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement.
    Siefken R; Klein-Hessling S; Serfling E; Kurrle R; Schwinzer R
    J Immunol; 1998 Aug; 161(4):1645-51. PubMed ID: 9712026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions.
    Maccalli C; Pisarra P; Vegetti C; Sensi M; Parmiani G; Anichini A
    J Immunol; 1999 Dec; 163(12):6912-23. PubMed ID: 10586094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function.
    Zhang T; He X; Tsang TC; Harris DT
    Cancer Gene Ther; 2004 Jul; 11(7):487-96. PubMed ID: 15153936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production.
    Schaft N; Lankiewicz B; Drexhage J; Berrevoets C; Moss DJ; Levitsky V; Bonneville M; Lee SP; McMichael AJ; Gratama JW; Bolhuis RL; Willemsen R; Debets R
    Int Immunol; 2006 Apr; 18(4):591-601. PubMed ID: 16507598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.
    Lamers CH; van Steenbergen-Langeveld S; van Brakel M; Groot-van Ruijven CM; van Elzakker PM; van Krimpen B; Sleijfer S; Debets R
    Hum Gene Ther Methods; 2014 Dec; 25(6):345-57. PubMed ID: 25423330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive antitumor immunotherapy in vitro and in vivo using genetically activated erbB2-specific T cells.
    Wang C; Hu W; Shen L; Dou R; Zhao S; Shan D; Yu K; Huang R; Li H
    J Immunother; 2014 Sep; 37(7):351-9. PubMed ID: 25075564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.
    Dagur PK; Sharma B; Kumar G; Khan NA; Katoch VM; Sengupta U; Joshi B
    Mol Immunol; 2010 Feb; 47(5):943-52. PubMed ID: 20018378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors.
    Lo AS; Ma Q; Liu DL; Junghans RP
    Clin Cancer Res; 2010 May; 16(10):2769-80. PubMed ID: 20460472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.